Bank of Montreal’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Bank of Montreal’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,800	Closed	-$519K	–	4442
2023 Q1	$519K	Sell	49,800 -600	-1%	-$6.21K	﹤0.01%	2438
2022 Q4	$518K	Sell	50,400 -22,740	-31%	-$230K	﹤0.01%	2585
2022 Q3	$736	Buy	+73,140	New	+$733K	﹤0.01%	2349

Bank of Montreal's LVAC Position: Q2 2023 in Review

Bank of Montreal sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 49,800 shares — an estimated $519K sold.

Bank of Montreal first reported a position in LVAC in Q3 2022 and held it in 3 quarters. The position peaked at $519K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Bank of Montreal reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Bank of Montreal sold 49,800 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $519K.
Bank of Montreal first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 3 quarters.
Bank of Montreal's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $519K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.